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Assessing the use of an essential health package





Background: The sector wide approach (SWAp) used in many developing countries is difficult to assess. One way
is to consider the essential health package (EHP) which is commonly the vehicle for a SWAp’s policies and plans.
It is not possible to measure the impact of an EHP by measuring health outcomes in countries such as Malawi.
But it is possible to assess the choice of interventions and their delivery in terms of coverage. This paper describes
an attempt to assess the Malawi SWAp through its EHP using these available measures of technical efficiency.
Methods: A burden of disease model was used to identify the priority diseases and their estimated incidence. Data from
the health management information system (HMIS) were usedt om e a s u r et h ec o v e r a g eo ft h e s ei n t e r v e n t i o n s .Ar e v i e w
of the cost-effectiveness of the chosen and potential interventions was undertaken to assess the appropriateness of each
intervention used in the EHP. Expenditure data were used to assess the level of funding of the EHP.
Results: 33 of the 55 EHP interventions were found to be potentially cost-effective (<$150/DALY), 12 were not so
cost-effective (>$150/DALY) and cost-effective estimates were not available for ten. 15 potential interventions,
which were cost-effective and tackling one of the top 20 ranked diseases, were identified.
Provision had increased in nearly all EHP services over the period of the SWAp. The rates of out patient
attendances and inpatient days per 1000 population had both increased from 929 attendances in 2002/3 to 1135
in 2007/08 and from 124 inpatient days in 2002/03 to 179 in 2007/08.
However, by 2007/08 the mean gap between what was required and what was provided was 0.68 of the
estimated need. Two services involving the treatment of malaria were overprovided, but the majority were
underprovided, with some such as maternity care providing less than half of what was required.
The EHP was under-funded throughout the period covering on average 57% of necessary costs. By 2007/08 the
funding paid by SWAp partners including the government of Malawi to fund the EHP was at US$13.5 per capita
per annum, which was almost half of the revised EHP estimated required expenditure per capita per annum.
Discussion: The SWAp had invested in some very cost-effective health interventions. In terms of numbers of
patients treated, the EHP had delivered two thirds of the services required. This was despite serious under-funding
of the EHP, an increase in the population and shortage of staff.
Conclusions: The identification of interventions of proven effectiveness and good value for money and earmarked
funding through a SWAp process can produce measurable improvement in health service delivery at extremely low cost.
Background
Donors may be prepared to relinquish individual health
projects and contribute to basket funding through a
SWAp so long as the health sector plans for which the
basket funding are used address health priorities in an
efficient and effective way. An EHP is commonly used
in a sector wide approach to identify cost-effective inter-
ventions chosen to address the most important health
problems of the country [1]. In a world of rational plan-
ning the outcomes of these chosen interventions would
be measured and the reduction in burden of disease cal-
culated. This would provide a way of assessing the over-
all cost-effectiveness of the approach. Unfortunately
measuring outcomes is not possible in countries like
Malawi, which does not have a vital registration system
or surveys to measure changes in morbidity. Instead,
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performed are required. This paper combines two ways
to assess the SWAp use of the EHP in Malawi.
The first way assesses whether sufficient services are
being provided to meet the essential health needs. It uses
estimates of incidences of the common diseases occur-
ring annually in the country. These are derived from
work to measure the burden of disease in the country
based on a WHO methodology [2,3]. The incidences are
compared to the numbers of patients treated for the dis-
eases which are included in the EHP. Services may be
overprovided for some diseases and underprovided for
others. The analysis provides an estimate of the coverage
for the specific interventions included in the EHP. The
limitation of the approach is that the analysis does not
measure outcomes or the quality of the service provided.
But adequate coverage is a prerequisite of an adequate
response to the identified health needs of the population
and so is a useful first measure of success.
The second way to assess the EHP is to review the
choice of interventions contained in the package and
identify those interventions that are tackling the most
important diseases and are good value for money.
Recent published work has identified cost-effective
assessments of many interventions in tropical popula-
tions [4]. Are there interventions that would be more
useful than those in the existing EHP?
A combination of an assessment of the choice and
coverage of an intervention in an EHP provides a proxi-
mate measure of its usefulness. This assessment com-
bined with knowing the overall cost of the EHP allows
SWAp partners to gauge its value and therefore the
SWAp’s contribution to the health sector.
What have other countries using a SWAp done to
assess performance? The SWAp in one country is
always different from that in another; some emphasise
its role in strengthening the policy framework, some the
financial framework, while others the institutional fra-
mework of its health sector [5]. Assessments of SWAp
have proved problematic whatever its prime purpose [1].
T h el a c ko fo u t c o m ed a t ai sw idespread [6]. The struc-
ture and content of a SWAp vary between countries [7]
and the formal structure of the relationships between
donors and recipients does not necessarily withstand
policy challenges [8]. A recent review in Zambia found a
limited increase in administrative efficiency, a reduction
in technical efficiency as shown by a drop in bed utilisa-
tion and no improvement in allocative efficiency [9].
Our study was designed to look solely at technical effi-
ciency, which we define as the efficient delivery of
health care to a population, through an analysis of the
appropriateness of the EHP interventions and their cov-
erage in 2008.
Methods
Estimating the burden of disease
WHO provided estimates of the burden of disease of
Malawi in 2002 and these were assessed and found to
be robust and useful for planning purposes [3]. Since
2002 the occurrence of some diseases has changed in
Malawi. Recent population based surveys indicate reduc-
tions in mortality. The latest such survey, a multiple
indicator cluster survey (MICS 2006) describes reduced
child and maternal mortality and an increase in impreg-
nated bed net use [10]. A recent report on HIV preva-
l e n c ep r e p a r e db yt h eM i n i s t r yo fH e a l t h( M O H )
estimates the recent trend in HIV prevalence and deaths
from AIDS [11], indicating that HIV prevalence has
levelled off but deaths have increased. The burden of
disease model was adjusted to take into account these
recent estimates of morbidity and mortality. Incidence
of the leading causes of disease burden as ranked by dis-
ability adjusted life years (DALYs) were derived from the
model and used to calculate the number of cases needed
to be served per 1000 population. Estimates of required
coverage used in a recently revised EHP costing exercise
were used as default values for interventions such as
family planning and immunisations.
Estimating coverage by the chosen EHP interventions
The health management information system (HMIS) has
been collecting performance data since 2001 and offers
evidence of changes in use of health facilities. Data col-
lected in the first year were not complete; more recent
data are more robust and can be analysed with some
degree of confidence [12]. The number of cases of each
EHP intervention provided in 2007/8 was calculated per
1000 population.
The rate ratio of provision (number of cases provided
for per 1000 population) to need (the number of cases
needed to be served per 1000 population) was calculated
for each EHP intervention. This gave an estimate of the
gap between what was provided and what was required,
and provided an assessment of how well the EHP had
met its objectives and how much more (or less) there
was to do.
Assessing the cost-effectiveness of current and potential
EHP interventions
The value of US$ 150 per DALY was used as the cut-off
point for cost-effective interventions. This was based on
recommendations of the WHO Ad Hoc Committee on
Health Research Priorities, which suggested that any
intervention costing less than US$ 150 per DALY
averted should be considered attractive in low-income
countries [13]. Values were taken from the publication -
Disease Control Priorities in Developing Countries [4],
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taken from a more recent publication [14]. Each inter-
vention already in the EHP was assessed to see if the
chosen intervention was cost-effective. All other inter-
ventions for which cost-effective studies have been
undertaken and which could be potentially useful in
reducing the top 20 diseases ranked by contribution to
the burden of disease (in DALYS) were also assessed.
Identifying EHP expenditure
Expenditure figures were derived from National Health
Accounts (NHAs) for financial years 2002/03 to 2005/6.
NHAs figures were not available for 2006/07 and 2007/
08 financial years and as such total donors, public and
private expenditures were not available for these years.
Instead, government and donor SWAp (pooled and ear-
marked) actual expenditure data from the MOH were
used to demonstrate the level of resources available for
the EHP for these financial years. The expenditure
figures did not include other funding sources such as
households, firms and parastatals, international non-
governmental organisations (NGOs) and donors outside
the SWAp.
Results
Burden of disease estimates
The total burden of disease (7.5 million DALYS) and the
top 20 ranked disease groups were estimated for 2008
(Table 1). HIV/AIDS was the top disease followed by
lower respiratory infections and malaria.
The burden in children under 15 years of age was 2.1
million DALYS, which accounted for 29% of the total
burden of disease in Malawi. Pneumonia was the top
disease followed by diarrhoeal disease and then malaria.
Malnutrition and neonatal illnesses took fifth and six
places in rank order after HIV/AIDS.
The burden of disease for adults was 72% of the total
burden of disease at 5.4 million DALYs. The leading
causes in adults were HIV/AIDS, followed by TB and cat-
aracts. TB and lower respiratory infection, which was
fourth place in adults, were likely to have been associated
with the HIV epidemic. Disabling conditions - cataract,
psychiatric disorders, and filariasis - caused significant
burden, being third, fifth and 17
th in the rank order.
Road traffic accidents were sixth in rank, followed by
reproductive health disorders despite affecting only half
the population. Indeed women bore a heavier burden of
disease than men - 59% in women as compared to 46% in
men. Disease burden due to abortion - meaning miscar-
riage and the effect of induced (criminal) abortion - was
the second most important disease in women.
Incidence estimates for each disease were available
from the global burden of disease (GBD) model. These
were used to calculate the number of patients requiring
the EHP interventions.
Estimating coverage of the EHP interventions
Coverage had increased for most services such as for
reproductive health, child services, immunisations and
H I V / A I D Ss i n c et h eS W A ps t a r t e d( T a b l e2 ) .T h er a t e
of out patient attendances and inpatient days per 1000
population had both increased from 929 attendances in
2002/03 to 1135 in 2007/08 and from 124 inpatient days
in 2002/03 to 179 in 2007/08 (Figure 1). The treatment
of acute respiratory infection in under 5 year old chil-
dren increased from 265/1000 to 348/1000 between
2004/05 and 2007/08.
By 2007/08 the gap between what was required and
what was provided was often narrow - the mean gap was
0.68 of estimated need (Table 3). A few services were
over-provided, such as the treatment of malaria - probably
due to the over-diagnosis of malaria in out-patients. Some
services needed to double - such as health facility deliv-
eries, the treatments of acute respiratory infection (ARI) in
under 5 year olds, of abortion complications and of acute
malnutrition, and supplementary feeding. A few services
were even more limited - dealing with complications of
pregnancy and the newborn, treatment of diarrhoea and
mother to child transmission (MTCT) prevention.
The cost-effectiveness of actual and potential EHP
interventions
33 of the 55 EHP interventions were found to be poten-
tially cost-effective (<$150/DALY), 12 were not so cost-
effective (>$150/DALY) and cost-effective estimates were
not available for 10 (Figure 2 and Additional File 1).
15 potential interventions, which were cost-effective and
tackling one of the top 20 ranked diseases, were
identified.
Pentavaccine was much less cost-effective ($298 per
DALY) than the basic DTP and measles vaccines, which
cost $7 to avert 1 DALY. Of interventions for TB, only the
directly observed short course treatment strategy (DOTS)
was cost-effective using the <$150/DALY criterion. The
chosen diarrhoeal disease intervention was very expensive
at $1060/DALY and the home remedy option would have
been much cheaper at $4/DALY. Antiretroviral therapy
(ART) was clearly not cost-effective at $922/DALY, along
with other treatments of AIDS in comparison with many
other interventions. Supplementary feeding for children
was not cost-effective at $225/DALY. All the other chosen
interventions were cost-effective.
In terms of potential interventions not yet included in
the EHP, those dealing with diseases which warranted
consideration because of their high burden rank were new
forms of malaria control, home made oral rehydration
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control measures for trypanosomiasis, treatment and con-
trol of trachoma, prevention of road traffic accidents, dis-
trict hospital based surgery, treatment of cataracts, mental
illness, epilepsy, ischaemic heart disease and stroke. In
addition there were interventions such as environmental
health improvements, school health, integrated manage-
ment of childhood illnesses (IMCI) and first aid that
would also tackle high burden diseases.
However, not all the potentially new interventions
were cost-effective. The ones which were less than $150
per DALY were intermittent prophylactic prevention
treatment (IPPT) of malaria in children at $3-12/DALY,
rapid diagnostic testing for malaria, indoor residual
spraying for malaria control, home made oral rehydra-
tion solution (ORS), mass treatment of soil helminths,
filariasis, onchocerciasis and trypanosomiasis, prevention
of road traffic accidents, problems requiring surgery,
improved water supplies and sanitation, IMCI, school
health, emergency services (ambulances and first aid)
and treatment of epilepsy and aspirin for stroke.
Overall cost of the EHP
In 2005/06 the national total expenditure on health
(excluding research, training, nutrition and environment
b u ti n c l u d i n go u to fp o c k e te x p e n d i t u r e )w a s$ 2 5p e r
capita (Figure 3), which was significantly short of the
Macroeconomics Commission estimated minimum cost
of $34 per capita in 2007 rising to $38 per capita in
2015 for essential services [15]. Over the first four years
of the SWAp period the funding provided 57% of the
necessary minimum financial resources needed. The
funding gap between national health expenditure and
the $34 per capita target reduced from 44% to 74%
between 2002/3 (the financial year before SWAp
started) and 2005/6. More recent figures were not avail-
able to identify trends of total health expenditure after
2005/06 but expenditure for the EHP provided by
SWAp partners rose from $7.9 in 2002/3 to $13.5 per
capita in 2007/8. These figures can be compared with
the estimated cost of the EHP in 2002/3 of $17.3 per
capita and revised in 2007/8 to $28.6 per capita. SWAp
funding had increased by 70% between 2002/3 and
2007/8 but by 2007/8 had not reached the expenditure
planned for 2002/3.
Discussion
Is the choice of EHP interventions appropriate?
Much of the cost-effectiveness analysis has been pub-
lished since the original choice for the Malawi EHP. For
instance the WHO-CHOICE initiative started in 2002
after the EHP had been chosen [16]. The considerable
harmony between that choice and the list of interven-
tions which have subsequently been found to be good
value can be seen as a considerable success. The exclu-
sions from that list are also notable. There was no
Table 1 Leading causes of burden of disease in 2008 - Malawi






1 HIV/AIDS 28.9 HIV/AIDS 24.9 HIV/AIDS 32.7
2 Lower respiratory infections 12.0 Lower respiratory infections 13.1 Lower respiratory infections 10.9
3 Malaria 8.6 Malaria 8.9 Malaria 8.4
4 Diarrhoeal diseases 8.4 Diarrhoeal diseases 8.8 Diarrhoeal diseases 8.0
5 Conditions arising during the
perinatal period
4.2 Conditions arising during the
perinatal period
5.9 Conditions arising during the
perinatal period
2.6
6 Tuberculosis 2.2 Tuberculosis 2.9 Protein-energy malnutrition 1.8
7 Protein-energy malnutrition 1.9 Road traffic accidents 2.2 Tuberculosis 1.5
8 Road traffic accidents 1.6 Protein-energy malnutrition 2.0 Cataracts 1.3
9 Cataracts 1.1 Drownings 1.2 Unipolar depressive disorders 1.2
10 Unipolar depressive disorders 1.0 Cataracts 1.0 Abortion 1.1
11 Cerebrovascular disease 0.8 Violence 0.8 Road traffic accidents 1.0
12 Drownings 0.7 Lymphatic filariasis 0.8 Maternal sepsis 1.0
13 Ischaemic heart disease 0.7 Ischaemic heart disease 0.8 Cerebrovascular disease 0.9
14 Abortion 0.6 Unipolar depressive disorders 0.8 Maternal haemorrhage 0.8
15 Iron-deficiency anaemia 0.5 Cerebrovascular disease 0.7 Trachoma 0.7
16 Iodine deficiency 0.5 Drug use disorders 0.6 Ischaemic heart disease 0.6
17 Congenital anomalies 0.5 Congenital anomalies 0.6 Iron-deficiency anaemia 0.6
18 Asthma 0.5 Fires 0.6 Iodine deficiency 0.5
19 Lymphatic filariasis 0.5 Iodine deficiency 0.6 Asthma 0.5
20 Violence 0.5 Asthma 0.6 Congenital anomalies 0.5
Bowie and Mwase Health Research Policy and Systems 2011, 9:4
http://www.health-policy-systems.com/content/9/1/4
Page 4 of 10cancer care; ART were introduced with the 3 by 5 initia-
tive after the EHP was originally designed; mental illness
was not included. The exclusions were tough and
appropriate.
The three weak choices were (i) the use of commercial
ORS, which was a policy error really belonging to WHO
and UNICEF [17], (ii) supplementary feeding of malnour-
ished children - another UNICEF/World Bank sacred
cow, which has never been found to be cost-effective [18]
and (iii) penta vaccine. If GAVI were to fail to fund this
expensive option in the future then the country could
revert to the more basic and cost-effective diphtheria,
tetanus and pertussis (DTP) vaccine regime. ART
deserves special consideration. It is clearly outside the
cost-effectiveness bracket of the EHP. Again, like penta
vaccine, it is wholly funded by an outside donor and if
Malawi had asked for Global funds to be used for other
interventions outside its remit, it is certain that the Glo-
bal Fund would have rejected the request. In terms of
cost-effectiveness of the EHP, so long as the Global fund
continues to fund ART and SWAp resources are not
diverted from more valuable interventions, the integrity
Table 2 Service provision of selected EHP interventions in all health facilities in Malawi from 2002/3 to 2007/8
Data element from HMIS Denominator per 1000 Financial year
02-03 03-04 04-05 05-06 06-07 07-08
Antenatal total visits live births 3057 1920 2694 2475 2320 2486
Delivery by skilled personnel live births 422 266 453 416 422 493
Woman with obstetric complication treated at obstetric care facility live births 46 28 30 31 33 39
Caesarean section live births 19 11 20 23 22 26
Abortion complications treated live births 16 17 21 23
Woman of reproductive age receiving modern family planning methods Female 15-45 651 435 221 159 137 160
BCG live births 633 561 936 951 957 1042
Pentavalent III live births 569 465 695 796 808 910
Polio-III live births 570 464 800 786 803 920
Measles 1st dose at 9 months live births 492 368 658 691 728 857
Vitamin A dose to 6 - 59 months population Under 5 323 0 373 372 346 579
Volunteer counselling confidential test and serostatus result 15-49 y Adult 15+ 12 0 26 43 66 103
HIV test positive 15-49 years Adult 15+ 6 10 13 20
HIV positive person receiving anti-retroviral treatment Adult 15+ 2 9 21 18
Pregnant woman receiving VCT and serostatus result Female 15-45 5 17 31 48
Pregnant woman tested HIV positive live births 9 25 43 60
Nevirapine dose to baby born to woman with HIV live births 1 2 2 4
Home-based Care patient followed-up and provided treatment Adult 15+ 8 13 17 23
Case treated as STI - new Adult 15+ 29 27 24 23
Child attending under-five clinic Under 5 2081 1321 2116 2193 2239 2571
Acute Respiratory Infections under 5 years - new Under 5 265 337 338 348
Diarrhoea non-bloody under 5 years - new Under 5 108 64 122 148 119 130
Malnutrition under 5 years - new Under 5 65 28 34 48 41 32
Malaria under 5 years - new Under 5 657 849 831 999
Malaria 5 years and older - new Over 5 194 215 220 251
Dysentery - new Total 6 4 7 7 8 8
Eye infection - new Total 26 32 23 27
Ear infection - new Total 6 10 12 10 10
Skin infection - new Total 32 40 34 37
Oral condition - new Total 25 29 27 29
Schistosomiasis - new Total 5 6 8 7
Leprosy - new Total 0 0 0 0
Common injuries and wounds Total 20 26 26 25
OPD total attendance Total 929 520 815 1058 911 1135
Admissions Total 35 19 49 53 55 58
Inpatient days Total 124 81 132 147 160 179
Inpatient discharges Total 39 46 49 56
Inpatient deaths (excluding maternity) Total 47 65 38 34 28 30
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staff being diverted from the EHP by ART clinics is well
documented and needs to be tackled [19].
There are some exciting interventions that can be
considered for inclusion in a revised EHP. The decision
to include them depends on whether donors and the
Government of Malawi (GOM) are prepared to fully
fund the current EHP. Fully funding the existing EHP
before embarking on new interventions is probably an
important principle to follow. However, the list is
tempting because the interventions are really good value
for money. Their cost effectiveness ratios are all below
$150/DALY, considerably less than the thresholds (mea-
sured in $/DALY) used in more developed countries
such as India ($2500), China ($5000), South Africa
($15,000) or England ($50,000) [20].
Is coverage adequate?
Despite the increase in the population, from 9.9 million
in 1998 to 13.1 million in 2008 [21], and the AIDS epi-
demic and despite the planned under-funding of the ori-
ginal EHP, the gap between what was needed and what
was provided was not wide. In terms of numbers of
patients treated, the EHP had delivered two thirds of the
services required. This can be considered a success.
Another study conducted by the Ministry of Health
found the equitable distribution of services had improved
o v e rt h el a s td e c a d e[ 2 2 ]s u g g e s t i n gt h a tt h eq u a l i t ya s
well as the quantity of coverage had improved. The EHP
is the chosen vehicle for the health sector’s contribution
to poverty reduction, and this provides some evidence of
its achievement in reducing inequalities. However, quality
of care is likely to have been compromised. The lack of
staff and the huge numbers of patients make this almost
inevitable [19]. As new staff from the emergency human
resources plan fill vacancies, improvements in quality will
be possible, a pre-requisite to reducing the burden of
disease.
The assessment of coverage was dependent on HMIS
data and therefore any analysis was limited by the data
quality. As identified in a recent Health Metrics report
on the health information systems in Malawi while
HMIS was present in all health facilities it was deemed
inadequate, with capacity and practices as well as disse-
mination needing improvements [12]. However the cov-
erage estimates are probably accurate enough for their
use at national level for this type of analysis where
annual totals of common interventions were used.
Is funding adequate?
The EHP expenditure figures only included SWAp and
government funds. This is not a major drawback since
the EHP was designed and costed by government as a




































































Figure 1 General activity health sector - Malawi 2002 - 2008.
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Page 6 of 10Table 3 Gap analysis showing the proportion of health needs met by the Essential Health Package - Malawi 2008
Interventions of the existing
Essential Health Package
National Incidence Levels
derived from Burden of
Disease estimates
Total burden to be met by
the EHP as cases per 1000
of the population
Provision in 2007/8
as cases per 1000 of
the population
The gap between need
and delivery (ratio of
provision to need)
a b b/a
Full immunization 58.5 41.9 0.72
Measles 45.1 39.4 0.87
ARI in under-5s 1,829,077 140 68.1 0.49
Malaria - bednets 1,200,000 91.8 91.8 1.00
Malaria - under 5 2,238,248 171.3 195.7 1.14
Malaria - 5 and over 1,932,413 147.9 208.2 1.41
Antenatal Care 797,313 61 45.7 0.75
Normal Delivery 637,850 43.9 22.7 0.52
Delivery complications 115,786 10.4 3.2 0.31
Newborn Complications 127,570 9.8 0.8 0.08
Abortion Complications 55,481 4.2 1.4 0.33
Treatment of Syphilis in
Pregnancy
31,095 2.4 2.2 0.92
Postpartum Care 637,850 48.8 13 0.27
Condoms 12,301 6.5 5 0.77
Oral Contraceptive Pill 10,854 7.8 6 0.77
Depo-provera injection 100,582 9.4 7.2 0.77
Norplant 2,894 0.1 0.1 1.00
IUCD 724 0.1 0.1 1.00
Bilateral Tubular Ligation 2.9 2.1 0.72
Vasectomy 0.1 0.1 1.00
Passive Case Detection 6.2 4.4 0.71
Treatment -smear negative and
extra-pulmonary TB
3.6 2.6 0.72
Treatment -smear positive TB 0.9 0.6 0.67
Treatment - relapsed cases 0.2 0.2 1.00
Treatment of Dehydration in
U5s
3,815,318 292 25.5 0.09




HIV Testing & Counselling
(HTC)
1,191,648 91.2 54.7 0.60
Management of OIs 261,325 20 12 0.60
Screening/treatment of syphilis 148,956 11.4 6.8 0.60
Prevention of MTC
transmission
78,137 12.2 0.6 0.05
Testing and Treatment of
Other STIs
436,676 33.4 12.8 0.38
CBHBC 37,892 2.9 0.8 0.28
ARV (adult) 79,200 5.6 3.4 0.61
ARV (child) 10,800 0.8 0.5 0.63
ARV Supplementary Feeding
(adult)
79,200 1 0.6 0.60
ARV Supplementary Feeding
(child)
10,800 0.9 0.5 0.56
Diagnosis and Case
Management
4,401,521 11.5 6.9 0.60
Mass Treatment 352,647 27 16.2 0.60
Growth Monitoring of U5
Children
2,383,085 182.4 183.2 1.00
Micronutrient supplementation 2,383,085 182.4 109.4 0.60
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44,162 3.4 1.4 0.41
Moderate Acute Malnutrition
(Outpatient)
40,375 3.1 2.5 0.81
Supplementary Feeding 244,732 18.7 7.7 0.41
Treatment of conjunctivitis 45.6 27.3 0.60
Acute otitis media in under 5s 1,089,317 7.3 4.4 0.60
Scabies - 62.6 37.6 0.60
Treatment of Fractures and
Dislocations
164,244 12.6 10.1 0.80
Treatment of Wounds 213,765 16.4 15.3 0.93
































































































Figure 2 The cost-effectiveness of and relationship to disease burden of actual and potential EHP interventions - Malawi 2008. 1I M C I ,2H I V
Testing & Counselling (HTC), 3 Management of OIs, 4 Prevention of MTC transmission, 5 CBHBC, 6 ARV, 7 ARI in under-5s, 8 Malaria - bednets, 9
Treatment of Dehydration in U5s using Tanzi, 10 Malaria - under 5 using ACT, 11 Treatment of Wounds, fractures and dislocations, 12 Maternal care, 13
Family planning, 14 Treatment -smear negative and extra-pulmonary TB, 15 Treatment -smear positive TB, 16 Treatment - relapsed cases, 17 Growth
Monitoring of U5 Children, 18 Testing and Treatment of Other Sexually Transmitted Infections (STIs), 19 Malaria - 5 and over using ACT, 20
Schistosomiasis mass treatment, 21 Full immunization with Penta vaccine, 22 Intermittent preventive treatment in pregnancy with SP, 23 Measles, 24
DPT, 25 Intermittent preventive treatment in children with SP, 26 Rapid diagnostic tests to improve malaria treatment, 27 Indoor residual spraying (two
rounds per year), 28 Home made ORS, 29 Onchocerciasis, 30 Mass treatment filariasis, 31 Case finding and treatment of Trypanosomiasis, 32
Supplementary Feeding, 33 Mass treatment of Trachoma, 34 Trachoma surgery, 35 Prevention of Road Traffic Accidents, 36 Improved water supply, 37
Improved sanitation, 38 Cholera or rotavirus immunisation, 39 School health, 40 Emergency medical care - first aid training of volunteers, 41
Emergency medical care - ambulance service, 42 Bipolar disorders, 43 Depression, 44 Schizophrenia, 45 Epilepsy, 46 Cataract extraction, 47 ACE
inhibitors, b-blockers and diuretics for CCF, 48 Aspirin, b-blockers and ACE inhibitors for IHD, 49 Aspirin for stroke, 50 Cancer.
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sources of funds such as households, international
NGOs, private firms and parastatals and donors outside
the SWAp were not party to this EHP and its funding
arrangements and indeed the MOH and partners in the
SWAp have no control on what they spend their funds.
Their control is on resources in the SWAp (pooled and
earmarked) which are meant to be spent on EHP.
F u n d i n ga tt h es t a r to ft h eS W A pw a sa p p r o x i m a t e l y
half the required amount - $18.4 as compared to $34 a
head - the base estimate from the Macroeconomics and
Health Commission. The revised costing of the EHP
estimated resources required to be $28.6 per capita,
with the increase largely coming from the Global Fund
money to pay for ART and associated AIDS care, new
artemesinin combination therapy and a maternity “Road
Map” to increase deliveries attended by skilled midwives.
The actual disbursement had always been less than
pledges from donors between 2002/3 and 2007/8, when
in this period only 62% of pledges were disbursed [23].
The net result was a serious under-funding of almost
half of the revised EHP estimated required expenditure
per capita per annum.
Technical efficiency
We were not able to measure outcomes. Taking antibio-
tic treatment of children with pneumonia as an example,
it would have been desirable to measure changes in
mortality in under 5 year old children from pneumonia.
I n s t e a dw eh a v ec o n f i r m e dan u m b e ro ft h i n g s .F i r s t ,
the identification and appropriate treatment of lower
respiratory infections though child clinics ($129 per
DALY saved) and IMCI ($39 per DALY saved) is poten-
tially a cost-effective intervention. Second, the disease
causes the biggest disease burden in Malawi children.
Third, the EHP delivered 68.1 treatments per 1000 in a
population with a need for 140 treatments per 1000, i.e.
half the required service. This was despite the increase
in the treatment rate of acute respiratory infections
from 265 per 1000 under 5 children in 2004/5 to 348/
1000 in 2007/8. For this particular intervention the gap
between need and provision remained wide.
A serious limitation of our study was the lack of infor-
mation about the quality of the appropriate intervention -
were children with pneumonia getting the correct
diagnosis and treatment? Operations research of IMCI
in Malawi has found significant numbers of missed
diagnoses and incorrect treatment.
A similar assessment was made for each of the EHP
interventions to assess these components of technical
efficiency. Quality assessment was available for some,
such as for caesarean section for disproportion [24].
However, the study found that the data to assess the
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Page 9 of 10can only relate to coverage and appropriateness of the
EHP interventions.
Conclusions
This assessment has shown that SWAp had invested in
some very cost-effective health interventions - indeed a
portfolio of interventions of far better value for money
than the range offered by donor governments in their
own countries. Despite serious under-funding of the
EHP, Malawi had achieved measurable improvements in
service delivery. This had been achieved in the face of a
human resource crisis, partly caused by a brain drain of
health staff and an AIDS epidemic. It is concluded that
the identification of interventions of proven effectiveness
and earmarked funding through a SWAp process can
produce measurable improvements in health service
delivery at extremely low cost.
Additional material
Additional file 1: Cost-effectiveness and importance of actual and
potential interventions - Malawi 2008. Cost-effective ratios (US$/DALY)
of existing and potential EHP interventions, categorised by (i) being
under or over $150/DALY threshold, (ii) the intervention dealing with
one of the top 20 diseases, (iii) an intervention found to be both cost
effective and high ranking for Malawi in 2008.
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